Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Various thoughts

<< Previous

Bullboard Posts

Next >>

Comment by Longholder99on Nov 30, 2023 7:33pm

277 Views

Post# 35762485

RE:RE:RE:Various thoughts

Dawg you seem adamant in many of your posts in bringing up this 6mos extension to the BTD timeline which is not in the company narrative, has not been mentioned by the FDA.... nor is it based in any real facts. With a company doing its best to work on a short leash for time and money. Do you not see where some would suspect this determination in suggesting a half year longer timeline is in store for BTD....which it clearly is not.....would seem purposeful?

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market